Clinical trials usually compare a limited number of screening options over a relatively short time horizon and it is unlikely that trial data will inform all relevant aspects of a screening programme. Decision analytic models provide a structure for synthezising information from various sources as well as analysing how the uncertainty affects the results.

Guidelines for economic evaluation of Health Technologies: Canada, 3rd edition, 2006, Guidelines for Pharmacoeconomic Evaluations in Belgium, 2008